rs2236957

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006030.4(CACNA2D2):​c.406-8827T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,938 control chromosomes in the GnomAD database, including 8,905 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 8905 hom., cov: 32)

Consequence

CACNA2D2
NM_006030.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.966
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.532 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA2D2NM_006030.4 linkuse as main transcriptc.406-8827T>C intron_variant ENST00000424201.7 NP_006021.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkuse as main transcriptc.406-8827T>C intron_variant 1 NM_006030.4 ENSP00000390329 P4Q9NY47-2

Frequencies

GnomAD3 genomes
AF:
0.288
AC:
43797
AN:
151818
Hom.:
8864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.390
Gnomad ASJ
AF:
0.0888
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.130
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.146
Gnomad OTH
AF:
0.240
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43888
AN:
151938
Hom.:
8905
Cov.:
32
AF XY:
0.288
AC XY:
21429
AN XY:
74296
show subpopulations
Gnomad4 AFR
AF:
0.538
Gnomad4 AMR
AF:
0.390
Gnomad4 ASJ
AF:
0.0888
Gnomad4 EAS
AF:
0.474
Gnomad4 SAS
AF:
0.129
Gnomad4 FIN
AF:
0.156
Gnomad4 NFE
AF:
0.146
Gnomad4 OTH
AF:
0.241
Alfa
AF:
0.235
Hom.:
770
Bravo
AF:
0.322
Asia WGS
AF:
0.291
AC:
1012
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.7
DANN
Benign
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2236957; hg19: chr3-50440426; API